domingo, 31 de mayo de 2026
To Rebuild Trust, FDA Should Start With The Accelerated Approval Program Anna Kaltenboeck May 28, 2026
https://www.healthaffairs.org/content/forefront/rebuild-trust-fda-should-start-accelerated-approval-program?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_TqfSG9SH05p9DdZiXX1l6xsth2kAbIUi4G9IeYGfWxwQV27KpqKq_eSCbclsCRjidHcSkbpU7qdZrE-T715IytXlRHw&_hsmi=421319073&utm_source=hasu
For serious conditions with high unmet need, earlier access to promising treatments can be worth the risk of greater uncertainty. But achieving this balance demands trust.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario